Does combining ipratropium bromide and salbutamol increase the systemic absorption of either component?

No, co-administration of ipratropium bromide and salbutamol sulfate in Combivent UDVs does not increase systemic absorption of either component; its additive activity results from their combined local effect on the lung following inhalation.